| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS, Director | C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE | /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook | 22 Aug 2025 | 0001870913 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIP | Common Stock | Sale | $4,243,773 | -47,012 | -8.8% | $90.27 | 484,908 | 20 Aug 2025 | Held by Esjay LLC | F1, F2 |
| transaction | ANIP | Common Stock | Sale | $4,792,235 | -52,988 | -11% | $90.44 | 431,920 | 21 Aug 2025 | Held by Esjay LLC | F2, F3 |
| holding | ANIP | Common Stock | 92,588 | 20 Aug 2025 | Direct | ||||||
| holding | ANIP | Common Stock | 5,000 | 20 Aug 2025 | Held by SS Pharma LLC | F4 |
| Id | Content |
|---|---|
| F1 | The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price. |
| F2 | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| F3 | The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price. |
| F4 | The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. |